Showing results (131-140 of 141) with videos related to
Sort By:
Pageof 15
International Journal of Molecular Sciences|November 28, 2018
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?Giovanni Duro, Carmela Zizzo, Giuseppe Cammarata, et al.European Journal of Human Genetics : EJHG|May 31, 2025
MYBPC3 c.2309-2A>G: exploring a founder variant in Italian hypertrophic cardiomyopathy patientsMarco Fabiani, Caterina Micolonghi, Silvia Caroselli, et al.JACC. Advances|June 28, 2024
Transcatheter Ablation of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy: A Multicenter Propensity Score-Based AnalysisAlessandro Pierri, Stefano Albani, Marco Merlo, et al.International Journal of Cardiology|September 13, 2024
Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathySaima Mushtaq, Mattia Chiesa, Valeria Novelli, et al.European Journal of Heart Failure|March 12, 2023
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network studyGiacomo Tini, Paolo Milani, Mattia Zampieri, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|February 17, 2026
Acute coronary syndrome and coronary artery disease in wild-type transthyretin amyloid cardiomyopathy: a DIAMOND sub-studyLaura De Michieli, Giacomo Tini, Alessia Argirò, et al.European Journal of Heart Failure|April 13, 2022
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide surveyMarco Merlo, Linda Pagura, Aldostefano Porcari, et al.JACC. Advances|May 13, 2025
The Diagnostic and Prognostic Value of the 12-Lead ECG in Arrhythmogenic Left Ventricular CardiomyopathyLeonardo Calò, Cinzia Crescenzi, Andrea Di Marco, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|June 27, 2025
Myosin-ATPase inhibitor in real-world patients with obstructive HCM: a report by the Cardiomyopathies and Pericardial Diseases WG of the Italian Society of CardiologyCesare de Gregorio, Paolo Bellocchi, Anna Rosa Napoli, et al.European Journal of Heart Failure|December 22, 2023
Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy populationEdoardo Bertero, Chiara Chiti, Maria Alessandra Schiavo, et al.Pageof 15